These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20018528)

  • 21. [The interactions of antiepileptic drugs in oncology practice].
    Armijo JA; Sánchez MB; Campos C; Adín J
    Rev Neurol; 2006 Jun 1-15; 42(11):681-90. PubMed ID: 16736404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-drug interactions between oral antiepileptics and oral anticancer drugs: implications to clinicians.
    Cheung YT; Yap KY; Chui WK; Chan A
    Eur Neurol; 2010; 64(2):88-94. PubMed ID: 20606454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable.
    Seden K; Back D; Khoo S
    J Antimicrob Chemother; 2009 Jul; 64(1):5-8. PubMed ID: 19398457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelines.
    de Marinis F; Rossi A; Di Maio M; Ricciardi S; Gridelli C;
    Lung Cancer; 2011 Jul; 73(1):1-10. PubMed ID: 21440325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Network analysis of adverse drug interactions.
    Takarabe M; Okuda S; Itoh M; Tokimatsu T; Goto S; Kanehisa M
    Genome Inform; 2008; 20():252-9. PubMed ID: 19425139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Capecitabine: a review.
    Walko CM; Lindley C
    Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy.
    Ismail M; Khan S; Khan F; Noor S; Sajid H; Yar S; Rasheed I
    BMC Cancer; 2020 Apr; 20(1):335. PubMed ID: 32307008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory metabolic drug interactions with newer psychotropic drugs: inclusion in package inserts and influences of concurrence in drug interaction screening software.
    Boyce RD; Collins C; Clayton M; Kloke J; Horn JR
    Ann Pharmacother; 2012 Oct; 46(10):1287-98. PubMed ID: 23032655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
    Rusthoven J; Bramwell V; Stephenson B
    Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P450-mediated cardiovascular drug interactions.
    Scheen AJ
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1065-82. PubMed ID: 21810031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review).
    Boulikas T; Vougiouka M
    Oncol Rep; 2004 Mar; 11(3):559-95. PubMed ID: 14767508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy regimens used in the treatment of gestational trophoblastic neoplasia at Philippine General Hospital: treatment outcomes and toxicity.
    Cagayan MS; Gacoba MC
    J Reprod Med; 2006 Nov; 51(11):907-18. PubMed ID: 17165439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-drug interactions in HIV positive cancer patients.
    Flepisi BT; Bouic P; Sissolak G; Rosenkranz B
    Biomed Pharmacother; 2014 Jun; 68(5):665-77. PubMed ID: 24863536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of drug-drug interactions in cancer patients treated at a university hospital in North Cyprus using two interaction databases.
    Laban AA; Birand N; Chukwunyere U; Abdi A; Basgut B
    Niger J Clin Pract; 2021 Jul; 24(7):1067-1071. PubMed ID: 34290184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OncoRx-IQ: a tool for quality assessment of online anticancer drug interactions.
    Yap KY; Raaj S; Chan A
    Int J Qual Health Care; 2010 Apr; 22(2):93-106. PubMed ID: 20172863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiepileptic treatment in paediatric oncology--an interdisciplinary challenge.
    Tibussek D; Distelmaier F; Schönberger S; Göbel U; Mayatepek E
    Klin Padiatr; 2006; 218(6):340-9. PubMed ID: 17080337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.
    Saito M; Hirata-Koizumi M; Urano T; Miyake S; Hasegawa R
    J Clin Pharm Ther; 2005 Feb; 30(1):21-37. PubMed ID: 15659001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.